Absci rises over 50% in pre-market after news that AMD will invest $20 million in it

2025-01-08 20:24:53

Absci rose more than 50% in pre-market trading, with news that AMD will invest $20 million in it.

Absci Corporation (NASDAQ: ABSI), a U.S. generative AI new drug discovery and development company, on Wednesday announced a strategic partnership with AMD.

The two companies will jointly deploy AMD Instinct accelerators and ROCm software to support key AI new drug discovery and development workloads, including Absci's from-scratch antibody design models.

As part of the partnership, AMD will also inject $20 million into Absci in the form of a private equity investment.

AMD

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Southwest Airlines CEO: Although Boeing still has a lot of work to do, they seem to be moving in a good direction and we are more optimistic.
                            2025-01-31

                                    White House Press Secretary Levitt: Details about the Nvidia meeting are still unclear.
                            2025-02-01

                                    Apple (AAPL.O) said the Apple Pay outage has been resolved.
                            2025-01-29

                                    Jefferies: Raised Meta Platforms (META.O) price target from $715 to $810.
                            2025-01-30

                                    Sam Altman, founder and CEO of OpenAI: OpenAI will develop specialized hardware for AI.
                            2025-02-03